Page last updated: 2024-08-21

diphenylamine and palbociclib

diphenylamine has been researched along with palbociclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Gong, M; Jiang, X; Li, J; Pek, M; Wu, X; Yatim, SMJM; Yu, Q; Zhang, F; Zheng, J	1

Other Studies

1 other study(ies) available for diphenylamine and palbociclib

Article	Year
Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer. Oncogene, 2017, 08-31, Volume: 36, Issue:35 Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Diphenylamine; Female; Gene Expression Profiling; HCT116 Cells; HT29 Cells; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyridines; Random Allocation; Xenograft Model Antitumor Assays	2017

Article

Year

Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer.

Oncogene, 2017, 08-31, Volume: 36, Issue:35

Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Diphenylamine; Female; Gene Expression Profiling; HCT116 Cells; HT29 Cells; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyridines; Random Allocation; Xenograft Model Antitumor Assays

2017